Clinical Trials on Atherogenic Dyslipidemia

Total 2810 results

Gaia AG
University Hospital, Aachen; Deutsche Stiftung für chronisch Kranke

Not yet recruiting

Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels (DIGICHOL)

Dyslipidemias | Hypercholesterolemia

Germany
EMS

Recruiting

Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment

Dyslipidemia | Hypertriglyceridemia

Brazil
The George Institute for Global Health, China
Ningxia Medical University

Completed

NUTS for the Prevention of Cardiovascular Disease in Chinese Adults (NUTS)

Cardiovascular Diseases | Dyslipidemias

China
Organon and Co

Completed

A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204) (MOBS)

Dyslipidemia | Hypercholesterolemia
Yonsei University

Completed

Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients

Dyslipidemias | Hypercholesterolemia

Korea, Republic of
Pfizer

Completed

Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin

Dyslipidemia | Hypercholesterolemia

United States
Casa de Saúde santa Marcelina

Completed

Effect of Polyvitaminics (Pyridoxine Hydrochloride, Folic Acid and Cyanocobalamin) in the Concentration of Homocysteine and Lipid Profile in Postmenopausal Women: a Randomized Controlled, Double-blind Clinical Trial

Dyslipidemias | Menopause | Homocystinaemia
University of Chile
Pontificia Universidad Catolica de Chile

Completed

Effect On Serum Cholesterol Of Dairy Products With Addition Of Esterified Phytosterols (ACTICOL)

Dyslipidemias | Hypercholesterolemia

Chile
Wenzhou Medical University

Terminated

The Therapeutic Effects of Statins and Berberine on the Hyperlipemia

Dyslipidemias

China
Pfizer

Withdrawn

Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia

Dyslipidemia | Hypercholesterolemia
Abbott

Completed

A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease

Dyslipidemia

Argentina, Czech Republic, Germany, Mexico, Poland, Romania, Russian Federation
Zydus Lifesciences Limited

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia

Dyslipidemia | Hypertriglyceridemia

India
AstraZeneca

Completed

A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia

Dyslipidemia | Hypercholesterolemia

United States
Takeda

Completed

Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.

Hypercholesterolemia

Poland, United Kingdom, Germany, South Africa, Finland, Estonia, Czech Republic
Kowa Research Europe

Completed

Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin

Dyslipidemia | Hypercholesterolemia

Finland, Italy, Norway, Russian Federation, United Kingdom
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial to Evaluate the Efficacy and Safety of CKD-386

Dyslipidemia Patients With Hypertension

Korea, Republic of
Lili Yang
Sun Yat-sen University

Enrolling by invitation

Regulation of Lipid Metabolism in Guangzhou Individuals With Dyslipidemia by Red Yeast Rice, Phytosterol Esters and Lycopene

Hypercholesterolemia

China
Cumberland Pharmaceuticals

Completed

Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients

Dyslipidemias | Hypercholesterolemia

United States
Novartis Pharmaceuticals

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients

Dyslipidemia | Healthy Volunteers

United States
Ache Laboratorios Farmaceuticos S.A.

Completed

Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia (LANCE)

Dyslipidemia | Hypercholesterolemia

Brazil
AstraZeneca

Completed

Rosuvastatin Adherence App Study in China (eHELP China)

Dyslipidemia | Hyperlipidemia

China
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337

Dyslipidemias

Korea, Republic of
Pfizer

Completed

A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins

Dyslipidemia | Hypercholesterolemia

United States, Canada
Elpen Pharmaceutical Co. Inc.

Completed

Atorvastatin Study in Cardiovascular Disease Risk (ANTLER)

Dyslipidemia | Hypercholesterolemia

Greece
Chong Kun Dang Pharmaceutical

Completed

Dyslipidemia in Cardiovascular Disease (KoLipilou)

Dyslipidemia
Medco Health Solutions, Inc.
Celera Genomics

Completed

Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS)

Cardiovascular Diseases | Dyslipidemia

United States
Hillel Yaffe Medical Center

Completed

Short Message Service (SMS) Impact on Patient Compliance Receiving Long Term Lipid Lowering Therapy With Statins

Dyslipidemia

Israel
Amgen

Completed

Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk (AMG145)

Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events

Japan
Ohio State University
National Institute on Minority Health and Health Disparities (NIMHD); National...

Completed

Genetic Influences on Statin Blood Concentrations in African Americans

Dyslipidemia | Hypercholesterolemia | Hyperlipidemia

United States
Kowa Research Institute, Inc.

Withdrawn

Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia

Dyslipidemia | Hyperlipidemia

United States
Shenzhen Center for Chronic Disease Control
Sun Yat-sen University

Completed

VDR SNPs & 25OHD Correlated With Dyslipidemia

Dyslipidemias | Single Nucleotide Polymorphism

China
Pfizer

Completed

Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia (SPIRE-AI)

Hyperlipidemia

United States
Raisio Group
Medfiles Ltd., Finland

Completed

Lipid Lowering Effect of a Cereal Based Snack Bar With Added Plant Stanol Ester

Dyslipidemias | Hypercholesterolemia | Hyperlipidemias
Raisio Group
University of Turku

Completed

Lipid-lowering Effect of Plant Stanol Ester Yoghurt Drinks

Dyslipidemias | Hypercholesterolemia | Hyperlipidemias
Raisio Group
Clinical Research Institute HUCH Ltd

Completed

Lipid-lowering Effect of a Plant Stanol Ester Supplement Product

Dyslipidemias | Hypercholesterolemia | Hyperlipidemias
Raisio Group

Completed

Lipid-lowering Effect of Plant Stanol Yogurt

Dyslipidemias | Hypercholesterolemia | Hyperlipidemias

Turkey
Boryung Pharmaceutical Co., Ltd

Completed

A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia

Essential Hypertension, Dyslipidemia

Korea, Republic of
Solvay Pharmaceuticals

Completed

Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes

Dyslipidemia/Glucose Metabolism Disorder

Poland, Ukraine, United Kingdom
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Effect of Dietary Intervention on LDL-C and Lipoprotein Subclasses Distribution in Patients With Hypercholesterolemia

Disease | Dyslipidemias | Hypercholesterolemia
Laboratorios Grossman, S.A.
Instituto Nacional de Salud Publica, Mexico

Unknown

Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population

Dyslipidemias | Cardiovascular Risk Factor

Mexico
Pfizer

Completed

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events (SPIRE-LL)

Hyperlipidemia

Finland, Netherlands, United States, Canada, Sweden, Korea, Republic of, Singapore, Czechia, Poland, United Kingdom, Puerto Rico, Norway
Pfizer

Completed

A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia

Metabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | Hypercholesterolemia | Hyperlipidemias

United States
Ohio State University
National Institute of General Medical Sciences (NIGMS)

Withdrawn

Genetic Influence on Statin Pharmacodynamics

Dyslipidemia | Hypercholesterolemia | Hyperlipidemia

United States
Catabasis Pharmaceuticals

Completed

Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia

Metabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | Hyperlipidemias | Hypertriglyceridemia

United States
Raisio Group
Indonesia University

Completed

Cholesterol-lowering Effects of Plant Stanol Ester

Dyslipidemias | Hypercholesterolemia | Hyperlipidemias
Solvay Pharmaceuticals

Completed

Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO

Dyslipidemia/Glucose Metabolism Disorder

Czech Republic, France, Hungary, India, Lithuania, Poland, Slovakia
Eli Lilly and Company

Active, not recruiting

A Study of LY3561774 in Participants With Mixed Dyslipidemia (PROLONG-ANG3)

Metabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | Hyperlipoproteinemia

United States, Mexico, Poland, Canada, Turkey, Japan, Argentina
Kowa Research Institute, Inc.

Withdrawn

Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia

Dyslipidemia | Hyperlipidemia

United States
Pfizer

Completed

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events (SPIRE-LDL)

Hyperlipidemia

United States, Spain, Taiwan, United Kingdom, Canada, Mexico, France, Hungary, Lithuania, Colombia, Romania, Russian Federation
Pfizer

Completed

Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events (SPIRE-HR)

Hyperlipidemia

Korea, Republic of, United States, Australia, Germany, Poland, Canada, Italy, Hong Kong, Czech Republic

Clinical Trials on Atherogenic Dyslipidemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations